#gene screening

[pathologylab]

#G2M's EGFR-Q Real-Time PCR Kit is an in vitro #diagnostic test intended for the qualitative #detection of #EGFR mutations in genomic #DNA extracted from fresh, frozen or formalin-fixed paraffin-embedded (FFPE) tissue. It is designed to selectively detect 21 different mutations across four exons i.e. exon 18, 19, 20, 21 for changes in EGFR #gene in tumor tissue.

Visit our website for more information. https://www.genes2me.com/ivd-real-time-pcr-test-kits/oncology-diagnostic-kit

For more details, Call us at [phone] or drop us an email at [email protected]

#RTPCR #EGFR #Lungcancer #pcr #Genes2me #testing #kits #solutions #madeinindia #india #manufacturer #poct #ivd

[pathologylab]

BRCA stands for Breast Cancer which is usually classified into Breast cancer Type 1 and Type 2. BRCA1 and BRAC2 genes are found in every normal individual but any genetic variation or mutations occurring in either of these two genes can lead to the incidence of breast and ovarian cancer. Genes2Me offers a thorough screening of BRCA1 and BRCA2 mutations, which helps in identifying the clinically relevant or pathogenic mutations. Book your test and know your risk for breast cancer and start your treatment early. #BreastCancer #BreastCancerAwareness #BRCA #Risk #Sequencing #Cancer #Genetics #Genes2Me #Mutation #G2M #Testing #GeneticTesting #RTPCR #Antigen For more details, Call us on 18001214030 or drop us an email at [email protected] for an Appointment To know more visit. https://t2m.io/brcas

[pathologylab]

Good luck, happiness, prosperity, and good health; may you get all this and much more on the happy occasion of Holi. Spreading the colors of love and joy on this occasion, Genes2Me wishes you a very happy Holi.#Holi #HoliCelebration #HoliFestival #Holi2022 #HappyHoli #HappyHoli2022 #GeneticTesting #Genes2Me

[mamamia0819]

siRNA Screening Service

High throughput siRNA screens are a powerful approach to study structural and functional relationships of genes and to identify novels parts of signaling pathways. This technology enables researchers to simultaneously screen thousands of loss-of-function genes and identify the association of genes with their corresponding biological phenotypes, such as, identifying novel proteins involved in disease pathways, defining the majority of proteins involved in specific repair pathways and identifying proteins that can be use for therapeutic targets.